Clover Health Investments (CLOV) Unveils 2027 Medicare Advantage Plans, Is The Stock Still A Bargain?

Why Clover Health’s 2027 Medicare Advantage update matters for CLOV

Clover Health Investments (CLOV) has just outlined its 2027 Medicare Advantage plans, highlighting $0 premium PPO options, low specialist copays, and wellness rewards, all built around its Clover Assistant technology for physicians.

Clover Health Investments has seen sharp share price swings this year, with the latest close at US$4.56 and a year to date share price return of 89.21% that contrasts with a slight 2.56% decline over the past 90 days. The recent 5.80% 7 day and 7.17% 30 day share price returns arrived alongside board refresh moves in late September and the 2027 Medicare Advantage plan reveal on 1 October. Longer term total shareholder return sits at 64.03% over one year and a very large gain over three years, offset by a 43.35% total shareholder return decline over five years, which suggests momentum has picked up recently after a much tougher earlier period for investors.

Spot 34 healthcare AI stocks that, like Clover Health Investments, aim to blend data driven care models with Medicare Advantage and broader healthcare delivery.

Clover Health Investments now pairs a tech heavy Medicare Advantage model with a sharply higher share price. The real tension for investors is whether that mix still offers fair value or already reflects the story in full.

Most Popular Narrative: 15% Undervalued

Clover Health Investments closed at $4.56, while the most followed narrative pegs fair value closer to $5.38. The current Medicare Advantage update is therefore being weighed against a story that already bakes in higher earnings power and margin improvement.

The company's differentiated technology-driven care model, particularly the Clover Assistant platform, positions it to benefit from the healthcare industry's accelerated shift toward technology adoption and data-driven, value-based care, supporting lower medical costs and higher medical margins, with positive implications for both revenue growth and net margins.

See why 48 investors see Clover Health Investments as 15% undervalued.

Result: Fair Value of $5.38 (UNDERVALUED)

Still, the bullish Clover Health Investments story can crack if higher medical and pharmacy utilization keeps squeezing benefit expense ratios, or if Medicare Advantage reimbursement rules turn less favorable.

Find out about the key risks to this Clover Health Investments narrative.

Next Steps

Mixed on Clover Health Investments so far, or leaning one way? Either way, move quickly and test the story against the underlying signals in 4 key rewards and 1 important warning sign.

Looking for more Clover Health style investment ideas?

If Clover Health Investments has your attention, do not stop here. Broader context from other stocks can sharpen your judgment and reveal opportunities you might otherwise miss.

• Target resilient compounding potential by reviewing the 29 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their underlying business profiles.
• Prioritize capital preservation and steadier rides by scanning the 31 resilient stocks with low risk scores that score well on balance sheet strength and risk indicators.
• Hunt for future leaders early by checking the 20 high quality undiscovered gems that pair solid financials with limited current market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com